XERIS BIOPHARMA HOLDINGS, INC. (XERS) Net margin 2020–2025
XERIS BIOPHARMA HOLDINGS, INC. (XERS) net profit margin by fiscal year — reported net income divided by reported revenue.
0.2%FY2025 · since FY2020: -452.2% → 0.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 0.2% | +27.2 pp |
| FY2024 | -27.0% | +11.0 pp |
| FY2023 | -38.0% | +47.9 pp |
| FY2022 | -85.9% | +161.6 pp |
| FY2021 | -247.5% | +204.7 pp |
| FY2020 | -452.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice